Skip to main content
Livermore
Livermore
ZHEN

aTYR PHARMA INC

ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001339970

No open-market purchases or sales by aTYR PHARMA INC insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $23.2M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding aTYR PHARMA INC changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ATYR: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders111289−20
Shares56.1M43.0K38.8M−17.2M (−30.6%)
Value$43.7M$33.5K$23.2M−$20.5M (−47.0%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (15)

Institutions that held aTYR PHARMA INC at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ATYR in Q2 2026
InstitutionSharesValue% of portfolio
Kalehua Capital Management LLC1,788,167$1.07M0.61%
Qube Research & Technologies Ltd126,996$75.8K0.00%
HRT Financial LP126,681$75.0K0.00%
Mariner, LLC58,658$35.0K0.00%
Schonfeld Strategic Advisors LLC50,880$30.4K0.00%
Alpha Wealth Funds, LLC50,000$29.9K0.02%
Point72 Asset Management, L.P.37,278$22.2K0.00%
Cerity Partners LLC29,232$17.4K0.00%
Y-Intercept (Hong Kong) Ltd22,373$13.4K0.00%
Abel Hall, LLC22,117$13.2K0.00%
SRS Capital Advisors, Inc.16,557$9.88K0.00%
Brighton Jones LLC11,458$6.84K0.00%
Clearstead Advisors, LLC861$5150.00%
IFG Advisory, LLC50$300.00%
Northwestern Mutual Wealth Management Co25$150.00%

Sold out (35)

Institutions that held aTYR PHARMA INC at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ATYR in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Vanguard Portfolio Management LLC569,227$444.0K
Nuveen, LLC229,284$178.8K
Charles Schwab Investment Management Inc210,737$164.4K
Bank of New York Mellon Corp193,531$151.0K
Deutsche Bank AG103,326$80.6K
Victory Capital Management Inc88,436$69.0K
Alliancebernstein L.P.64,480$50.5K
Redhawk Wealth Advisors, Inc.49,150$38.3K
Invesco Ltd.46,354$36.2K
Price T Rowe Associates Inc46,126$36.0K
Mirae Asset Global ETFs Holdings Ltd.46,073$35.9K
Belpointe Asset Management LLC45,738$35.7K
SEI Investments Co33,829$26.4K
New York State Common Retirement Fund27,500$21.4K
Intech Investment Management LLC26,187$20.4K
Police & Firemen's Retirement System of New Jersey26,081$20.3K
Neuberger Berman Group LLC21,743$17.0K
RBF Capital, LLC20,000$15.6K
Prudential Financial Inc14,660$11.4K
ProShare Advisors LLC13,905$10.8K
Crossmark Global Holdings, Inc.12,666$9.88K
Pasadena Private Wealth, LLC12,228$9.54K
Apollon Wealth Management, LLC11,900$9.28K
Russell Investments Group, Ltd.11,361$8.86K
Manufacturers Life Insurance Company, The10,552$8.23K
Voya Investment Management LLC10,338$8.06K
Ameritas Investment Partners, Inc.8,881$6.93K
Legal & General Group Plc7,920$6.18K
California State Teachers Retirement System5,190$4.05K
Advisor Group Holdings, Inc.5,000$3.90K
Toth Financial Advisory Corp1,400$1.09K
Simplex Trading, LLC1,335$1.04K
Sterling Capital Management LLC742$579
Wealth Preservation Advisors, LLC157$122
Root Financial Partners, LLC9$7

Not filed for Q2 2026 yet (2)

Institutions that held aTYR PHARMA INC at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ATYR in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC36,010$28.1K
My Portfolio Guide, LLC7,000$5.46K